ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Digital Therapeutics for Nervous System Diseases Market Research Report 2025
Published Date: April 2025
|
Report Code: QYRE-Auto-33G12998
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Digital Therapeutics for Nervous System Diseases Market Research Report 2023
BUY CHAPTERS

Global Digital Therapeutics for Nervous System Diseases Market Research Report 2025

Code: QYRE-Auto-33G12998
Report
April 2025
Pages:86
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Sanofi
Nanjing Vishee Medical Technology Co.,Ltd.
Wonderlab
Zoecare
66nao
MedRhythms
Curelator
GYENNO SCIENCE
Cognito Therapeutics
Glecan
Xinkangyx
BestCovered, Ltd.

Digital Therapeutics for Nervous System Diseases Market

The global market for Digital Therapeutics for Nervous System Diseases was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Digital Therapeutics for Nervous System Diseases are software program-driven, evidence-based interventions to treat, manage, or prevent nervous system diseases.
North American market for Digital Therapeutics for Nervous System Diseases is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Digital Therapeutics for Nervous System Diseases is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Digital Therapeutics for Nervous System Diseases in Epilepsy is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Digital Therapeutics for Nervous System Diseases include Zoecare, 66nao, MedRhythms, Curelator, Sanofi, GYENNO SCIENCE, Cognito Therapeutics, Nanjing Vishee Medical Technology Co.,Ltd., Glecan, Xinkangyx, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Digital Therapeutics for Nervous System Diseases, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Digital Therapeutics for Nervous System Diseases.
The Digital Therapeutics for Nervous System Diseases market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Digital Therapeutics for Nervous System Diseases market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Digital Therapeutics for Nervous System Diseases companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Digital Therapeutics for Nervous System Diseases Market Report

Report Metric Details
Report Name Digital Therapeutics for Nervous System Diseases Market
Segment by Type
Segment by Application
  • Epilepsy
  • Parkinson's Disease
  • Alzheimer's Disease
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Zoecare, 66nao, MedRhythms, Curelator, Sanofi, GYENNO SCIENCE, Cognito Therapeutics, Nanjing Vishee Medical Technology Co.,Ltd., Glecan, Xinkangyx, WonderLab, BestCovered, Ltd.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Digital Therapeutics for Nervous System Diseases company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Digital Therapeutics for Nervous System Diseases Market report?

Ans: The main players in the Digital Therapeutics for Nervous System Diseases Market are Zoecare, 66nao, MedRhythms, Curelator, Sanofi, GYENNO SCIENCE, Cognito Therapeutics, Nanjing Vishee Medical Technology Co.,Ltd., Glecan, Xinkangyx, WonderLab, BestCovered, Ltd.

What are the Application segmentation covered in the Digital Therapeutics for Nervous System Diseases Market report?

Ans: The Applications covered in the Digital Therapeutics for Nervous System Diseases Market report are Epilepsy, Parkinson's Disease, Alzheimer's Disease, Other

What are the Type segmentation covered in the Digital Therapeutics for Nervous System Diseases Market report?

Ans: The Types covered in the Digital Therapeutics for Nervous System Diseases Market report are Prevention, Management, Treatment

Recommended Reports

Digital Therapeutics

Nervous System Drugs

Neurologic Disorder Treatment

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Digital Therapeutics for Nervous System Diseases Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Prevention
1.2.3 Management
1.2.4 Treatment
1.3 Market by Application
1.3.1 Global Digital Therapeutics for Nervous System Diseases Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Epilepsy
1.3.3 Parkinson's Disease
1.3.4 Alzheimer's Disease
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Digital Therapeutics for Nervous System Diseases Market Perspective (2020-2031)
2.2 Global Digital Therapeutics for Nervous System Diseases Growth Trends by Region
2.2.1 Global Digital Therapeutics for Nervous System Diseases Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Digital Therapeutics for Nervous System Diseases Historic Market Size by Region (2020-2025)
2.2.3 Digital Therapeutics for Nervous System Diseases Forecasted Market Size by Region (2026-2031)
2.3 Digital Therapeutics for Nervous System Diseases Market Dynamics
2.3.1 Digital Therapeutics for Nervous System Diseases Industry Trends
2.3.2 Digital Therapeutics for Nervous System Diseases Market Drivers
2.3.3 Digital Therapeutics for Nervous System Diseases Market Challenges
2.3.4 Digital Therapeutics for Nervous System Diseases Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Digital Therapeutics for Nervous System Diseases Players by Revenue
3.1.1 Global Top Digital Therapeutics for Nervous System Diseases Players by Revenue (2020-2025)
3.1.2 Global Digital Therapeutics for Nervous System Diseases Revenue Market Share by Players (2020-2025)
3.2 Global Digital Therapeutics for Nervous System Diseases Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Digital Therapeutics for Nervous System Diseases Revenue
3.4 Global Digital Therapeutics for Nervous System Diseases Market Concentration Ratio
3.4.1 Global Digital Therapeutics for Nervous System Diseases Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Digital Therapeutics for Nervous System Diseases Revenue in 2024
3.5 Global Key Players of Digital Therapeutics for Nervous System Diseases Head office and Area Served
3.6 Global Key Players of Digital Therapeutics for Nervous System Diseases, Product and Application
3.7 Global Key Players of Digital Therapeutics for Nervous System Diseases, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Digital Therapeutics for Nervous System Diseases Breakdown Data by Type
4.1 Global Digital Therapeutics for Nervous System Diseases Historic Market Size by Type (2020-2025)
4.2 Global Digital Therapeutics for Nervous System Diseases Forecasted Market Size by Type (2026-2031)
5 Digital Therapeutics for Nervous System Diseases Breakdown Data by Application
5.1 Global Digital Therapeutics for Nervous System Diseases Historic Market Size by Application (2020-2025)
5.2 Global Digital Therapeutics for Nervous System Diseases Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Digital Therapeutics for Nervous System Diseases Market Size (2020-2031)
6.2 North America Digital Therapeutics for Nervous System Diseases Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Digital Therapeutics for Nervous System Diseases Market Size by Country (2020-2025)
6.4 North America Digital Therapeutics for Nervous System Diseases Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Digital Therapeutics for Nervous System Diseases Market Size (2020-2031)
7.2 Europe Digital Therapeutics for Nervous System Diseases Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Digital Therapeutics for Nervous System Diseases Market Size by Country (2020-2025)
7.4 Europe Digital Therapeutics for Nervous System Diseases Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Digital Therapeutics for Nervous System Diseases Market Size (2020-2031)
8.2 Asia-Pacific Digital Therapeutics for Nervous System Diseases Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Digital Therapeutics for Nervous System Diseases Market Size by Region (2020-2025)
8.4 Asia-Pacific Digital Therapeutics for Nervous System Diseases Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Digital Therapeutics for Nervous System Diseases Market Size (2020-2031)
9.2 Latin America Digital Therapeutics for Nervous System Diseases Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Digital Therapeutics for Nervous System Diseases Market Size by Country (2020-2025)
9.4 Latin America Digital Therapeutics for Nervous System Diseases Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Digital Therapeutics for Nervous System Diseases Market Size (2020-2031)
10.2 Middle East & Africa Digital Therapeutics for Nervous System Diseases Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Digital Therapeutics for Nervous System Diseases Market Size by Country (2020-2025)
10.4 Middle East & Africa Digital Therapeutics for Nervous System Diseases Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Zoecare
11.1.1 Zoecare Company Details
11.1.2 Zoecare Business Overview
11.1.3 Zoecare Digital Therapeutics for Nervous System Diseases Introduction
11.1.4 Zoecare Revenue in Digital Therapeutics for Nervous System Diseases Business (2020-2025)
11.1.5 Zoecare Recent Development
11.2 66nao
11.2.1 66nao Company Details
11.2.2 66nao Business Overview
11.2.3 66nao Digital Therapeutics for Nervous System Diseases Introduction
11.2.4 66nao Revenue in Digital Therapeutics for Nervous System Diseases Business (2020-2025)
11.2.5 66nao Recent Development
11.3 MedRhythms
11.3.1 MedRhythms Company Details
11.3.2 MedRhythms Business Overview
11.3.3 MedRhythms Digital Therapeutics for Nervous System Diseases Introduction
11.3.4 MedRhythms Revenue in Digital Therapeutics for Nervous System Diseases Business (2020-2025)
11.3.5 MedRhythms Recent Development
11.4 Curelator
11.4.1 Curelator Company Details
11.4.2 Curelator Business Overview
11.4.3 Curelator Digital Therapeutics for Nervous System Diseases Introduction
11.4.4 Curelator Revenue in Digital Therapeutics for Nervous System Diseases Business (2020-2025)
11.4.5 Curelator Recent Development
11.5 Sanofi
11.5.1 Sanofi Company Details
11.5.2 Sanofi Business Overview
11.5.3 Sanofi Digital Therapeutics for Nervous System Diseases Introduction
11.5.4 Sanofi Revenue in Digital Therapeutics for Nervous System Diseases Business (2020-2025)
11.5.5 Sanofi Recent Development
11.6 GYENNO SCIENCE
11.6.1 GYENNO SCIENCE Company Details
11.6.2 GYENNO SCIENCE Business Overview
11.6.3 GYENNO SCIENCE Digital Therapeutics for Nervous System Diseases Introduction
11.6.4 GYENNO SCIENCE Revenue in Digital Therapeutics for Nervous System Diseases Business (2020-2025)
11.6.5 GYENNO SCIENCE Recent Development
11.7 Cognito Therapeutics
11.7.1 Cognito Therapeutics Company Details
11.7.2 Cognito Therapeutics Business Overview
11.7.3 Cognito Therapeutics Digital Therapeutics for Nervous System Diseases Introduction
11.7.4 Cognito Therapeutics Revenue in Digital Therapeutics for Nervous System Diseases Business (2020-2025)
11.7.5 Cognito Therapeutics Recent Development
11.8 Nanjing Vishee Medical Technology Co.,Ltd.
11.8.1 Nanjing Vishee Medical Technology Co.,Ltd. Company Details
11.8.2 Nanjing Vishee Medical Technology Co.,Ltd. Business Overview
11.8.3 Nanjing Vishee Medical Technology Co.,Ltd. Digital Therapeutics for Nervous System Diseases Introduction
11.8.4 Nanjing Vishee Medical Technology Co.,Ltd. Revenue in Digital Therapeutics for Nervous System Diseases Business (2020-2025)
11.8.5 Nanjing Vishee Medical Technology Co.,Ltd. Recent Development
11.9 Glecan
11.9.1 Glecan Company Details
11.9.2 Glecan Business Overview
11.9.3 Glecan Digital Therapeutics for Nervous System Diseases Introduction
11.9.4 Glecan Revenue in Digital Therapeutics for Nervous System Diseases Business (2020-2025)
11.9.5 Glecan Recent Development
11.10 Xinkangyx
11.10.1 Xinkangyx Company Details
11.10.2 Xinkangyx Business Overview
11.10.3 Xinkangyx Digital Therapeutics for Nervous System Diseases Introduction
11.10.4 Xinkangyx Revenue in Digital Therapeutics for Nervous System Diseases Business (2020-2025)
11.10.5 Xinkangyx Recent Development
11.11 WonderLab
11.11.1 WonderLab Company Details
11.11.2 WonderLab Business Overview
11.11.3 WonderLab Digital Therapeutics for Nervous System Diseases Introduction
11.11.4 WonderLab Revenue in Digital Therapeutics for Nervous System Diseases Business (2020-2025)
11.11.5 WonderLab Recent Development
11.12 BestCovered, Ltd.
11.12.1 BestCovered, Ltd. Company Details
11.12.2 BestCovered, Ltd. Business Overview
11.12.3 BestCovered, Ltd. Digital Therapeutics for Nervous System Diseases Introduction
11.12.4 BestCovered, Ltd. Revenue in Digital Therapeutics for Nervous System Diseases Business (2020-2025)
11.12.5 BestCovered, Ltd. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Sanofi
Nanjing Vishee Medical Technology Co.,Ltd.
Wonderlab
Zoecare
66nao
MedRhythms
Curelator
GYENNO SCIENCE
Cognito Therapeutics
Glecan
Xinkangyx
BestCovered, Ltd.
List of Tables
 Table 1. Global Digital Therapeutics for Nervous System Diseases Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Prevention
 Table 3. Key Players of Management
 Table 4. Key Players of Treatment
 Table 5. Global Digital Therapeutics for Nervous System Diseases Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Digital Therapeutics for Nervous System Diseases Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Digital Therapeutics for Nervous System Diseases Market Size by Region (2020-2025) & (US$ Million)
 Table 8. Global Digital Therapeutics for Nervous System Diseases Market Share by Region (2020-2025)
 Table 9. Global Digital Therapeutics for Nervous System Diseases Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 10. Global Digital Therapeutics for Nervous System Diseases Market Share by Region (2026-2031)
 Table 11. Digital Therapeutics for Nervous System Diseases Market Trends
 Table 12. Digital Therapeutics for Nervous System Diseases Market Drivers
 Table 13. Digital Therapeutics for Nervous System Diseases Market Challenges
 Table 14. Digital Therapeutics for Nervous System Diseases Market Restraints
 Table 15. Global Digital Therapeutics for Nervous System Diseases Revenue by Players (2020-2025) & (US$ Million)
 Table 16. Global Digital Therapeutics for Nervous System Diseases Market Share by Players (2020-2025)
 Table 17. Global Top Digital Therapeutics for Nervous System Diseases Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Digital Therapeutics for Nervous System Diseases as of 2024)
 Table 18. Ranking of Global Top Digital Therapeutics for Nervous System Diseases Companies by Revenue (US$ Million) in 2024
 Table 19. Global 5 Largest Players Market Share by Digital Therapeutics for Nervous System Diseases Revenue (CR5 and HHI) & (2020-2025)
 Table 20. Global Key Players of Digital Therapeutics for Nervous System Diseases, Headquarters and Area Served
 Table 21. Global Key Players of Digital Therapeutics for Nervous System Diseases, Product and Application
 Table 22. Global Key Players of Digital Therapeutics for Nervous System Diseases, Date of Enter into This Industry
 Table 23. Mergers & Acquisitions, Expansion Plans
 Table 24. Global Digital Therapeutics for Nervous System Diseases Market Size by Type (2020-2025) & (US$ Million)
 Table 25. Global Digital Therapeutics for Nervous System Diseases Revenue Market Share by Type (2020-2025)
 Table 26. Global Digital Therapeutics for Nervous System Diseases Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 27. Global Digital Therapeutics for Nervous System Diseases Revenue Market Share by Type (2026-2031)
 Table 28. Global Digital Therapeutics for Nervous System Diseases Market Size by Application (2020-2025) & (US$ Million)
 Table 29. Global Digital Therapeutics for Nervous System Diseases Revenue Market Share by Application (2020-2025)
 Table 30. Global Digital Therapeutics for Nervous System Diseases Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 31. Global Digital Therapeutics for Nervous System Diseases Revenue Market Share by Application (2026-2031)
 Table 32. North America Digital Therapeutics for Nervous System Diseases Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 33. North America Digital Therapeutics for Nervous System Diseases Market Size by Country (2020-2025) & (US$ Million)
 Table 34. North America Digital Therapeutics for Nervous System Diseases Market Size by Country (2026-2031) & (US$ Million)
 Table 35. Europe Digital Therapeutics for Nervous System Diseases Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 36. Europe Digital Therapeutics for Nervous System Diseases Market Size by Country (2020-2025) & (US$ Million)
 Table 37. Europe Digital Therapeutics for Nervous System Diseases Market Size by Country (2026-2031) & (US$ Million)
 Table 38. Asia-Pacific Digital Therapeutics for Nervous System Diseases Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 39. Asia-Pacific Digital Therapeutics for Nervous System Diseases Market Size by Region (2020-2025) & (US$ Million)
 Table 40. Asia-Pacific Digital Therapeutics for Nervous System Diseases Market Size by Region (2026-2031) & (US$ Million)
 Table 41. Latin America Digital Therapeutics for Nervous System Diseases Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 42. Latin America Digital Therapeutics for Nervous System Diseases Market Size by Country (2020-2025) & (US$ Million)
 Table 43. Latin America Digital Therapeutics for Nervous System Diseases Market Size by Country (2026-2031) & (US$ Million)
 Table 44. Middle East & Africa Digital Therapeutics for Nervous System Diseases Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 45. Middle East & Africa Digital Therapeutics for Nervous System Diseases Market Size by Country (2020-2025) & (US$ Million)
 Table 46. Middle East & Africa Digital Therapeutics for Nervous System Diseases Market Size by Country (2026-2031) & (US$ Million)
 Table 47. Zoecare Company Details
 Table 48. Zoecare Business Overview
 Table 49. Zoecare Digital Therapeutics for Nervous System Diseases Product
 Table 50. Zoecare Revenue in Digital Therapeutics for Nervous System Diseases Business (2020-2025) & (US$ Million)
 Table 51. Zoecare Recent Development
 Table 52. 66nao Company Details
 Table 53. 66nao Business Overview
 Table 54. 66nao Digital Therapeutics for Nervous System Diseases Product
 Table 55. 66nao Revenue in Digital Therapeutics for Nervous System Diseases Business (2020-2025) & (US$ Million)
 Table 56. 66nao Recent Development
 Table 57. MedRhythms Company Details
 Table 58. MedRhythms Business Overview
 Table 59. MedRhythms Digital Therapeutics for Nervous System Diseases Product
 Table 60. MedRhythms Revenue in Digital Therapeutics for Nervous System Diseases Business (2020-2025) & (US$ Million)
 Table 61. MedRhythms Recent Development
 Table 62. Curelator Company Details
 Table 63. Curelator Business Overview
 Table 64. Curelator Digital Therapeutics for Nervous System Diseases Product
 Table 65. Curelator Revenue in Digital Therapeutics for Nervous System Diseases Business (2020-2025) & (US$ Million)
 Table 66. Curelator Recent Development
 Table 67. Sanofi Company Details
 Table 68. Sanofi Business Overview
 Table 69. Sanofi Digital Therapeutics for Nervous System Diseases Product
 Table 70. Sanofi Revenue in Digital Therapeutics for Nervous System Diseases Business (2020-2025) & (US$ Million)
 Table 71. Sanofi Recent Development
 Table 72. GYENNO SCIENCE Company Details
 Table 73. GYENNO SCIENCE Business Overview
 Table 74. GYENNO SCIENCE Digital Therapeutics for Nervous System Diseases Product
 Table 75. GYENNO SCIENCE Revenue in Digital Therapeutics for Nervous System Diseases Business (2020-2025) & (US$ Million)
 Table 76. GYENNO SCIENCE Recent Development
 Table 77. Cognito Therapeutics Company Details
 Table 78. Cognito Therapeutics Business Overview
 Table 79. Cognito Therapeutics Digital Therapeutics for Nervous System Diseases Product
 Table 80. Cognito Therapeutics Revenue in Digital Therapeutics for Nervous System Diseases Business (2020-2025) & (US$ Million)
 Table 81. Cognito Therapeutics Recent Development
 Table 82. Nanjing Vishee Medical Technology Co.,Ltd. Company Details
 Table 83. Nanjing Vishee Medical Technology Co.,Ltd. Business Overview
 Table 84. Nanjing Vishee Medical Technology Co.,Ltd. Digital Therapeutics for Nervous System Diseases Product
 Table 85. Nanjing Vishee Medical Technology Co.,Ltd. Revenue in Digital Therapeutics for Nervous System Diseases Business (2020-2025) & (US$ Million)
 Table 86. Nanjing Vishee Medical Technology Co.,Ltd. Recent Development
 Table 87. Glecan Company Details
 Table 88. Glecan Business Overview
 Table 89. Glecan Digital Therapeutics for Nervous System Diseases Product
 Table 90. Glecan Revenue in Digital Therapeutics for Nervous System Diseases Business (2020-2025) & (US$ Million)
 Table 91. Glecan Recent Development
 Table 92. Xinkangyx Company Details
 Table 93. Xinkangyx Business Overview
 Table 94. Xinkangyx Digital Therapeutics for Nervous System Diseases Product
 Table 95. Xinkangyx Revenue in Digital Therapeutics for Nervous System Diseases Business (2020-2025) & (US$ Million)
 Table 96. Xinkangyx Recent Development
 Table 97. WonderLab Company Details
 Table 98. WonderLab Business Overview
 Table 99. WonderLab Digital Therapeutics for Nervous System Diseases Product
 Table 100. WonderLab Revenue in Digital Therapeutics for Nervous System Diseases Business (2020-2025) & (US$ Million)
 Table 101. WonderLab Recent Development
 Table 102. BestCovered, Ltd. Company Details
 Table 103. BestCovered, Ltd. Business Overview
 Table 104. BestCovered, Ltd. Digital Therapeutics for Nervous System Diseases Product
 Table 105. BestCovered, Ltd. Revenue in Digital Therapeutics for Nervous System Diseases Business (2020-2025) & (US$ Million)
 Table 106. BestCovered, Ltd. Recent Development
 Table 107. Research Programs/Design for This Report
 Table 108. Key Data Information from Secondary Sources
 Table 109. Key Data Information from Primary Sources
 Table 110. Authors List of This Report


List of Figures
 Figure 1. Digital Therapeutics for Nervous System Diseases Picture
 Figure 2. Global Digital Therapeutics for Nervous System Diseases Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Digital Therapeutics for Nervous System Diseases Market Share by Type: 2024 VS 2031
 Figure 4. Prevention Features
 Figure 5. Management Features
 Figure 6. Treatment Features
 Figure 7. Global Digital Therapeutics for Nervous System Diseases Market Size by Application (2020-2031) & (US$ Million)
 Figure 8. Global Digital Therapeutics for Nervous System Diseases Market Share by Application: 2024 VS 2031
 Figure 9. Epilepsy Case Studies
 Figure 10. Parkinson's Disease Case Studies
 Figure 11. Alzheimer's Disease Case Studies
 Figure 12. Other Case Studies
 Figure 13. Digital Therapeutics for Nervous System Diseases Report Years Considered
 Figure 14. Global Digital Therapeutics for Nervous System Diseases Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 15. Global Digital Therapeutics for Nervous System Diseases Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 16. Global Digital Therapeutics for Nervous System Diseases Market Share by Region: 2024 VS 2031
 Figure 17. Global Digital Therapeutics for Nervous System Diseases Market Share by Players in 2024
 Figure 18. Global Top Digital Therapeutics for Nervous System Diseases Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Digital Therapeutics for Nervous System Diseases as of 2024)
 Figure 19. The Top 10 and 5 Players Market Share by Digital Therapeutics for Nervous System Diseases Revenue in 2024
 Figure 20. North America Digital Therapeutics for Nervous System Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. North America Digital Therapeutics for Nervous System Diseases Market Share by Country (2020-2031)
 Figure 22. United States Digital Therapeutics for Nervous System Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Canada Digital Therapeutics for Nervous System Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Digital Therapeutics for Nervous System Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe Digital Therapeutics for Nervous System Diseases Market Share by Country (2020-2031)
 Figure 26. Germany Digital Therapeutics for Nervous System Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. France Digital Therapeutics for Nervous System Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. U.K. Digital Therapeutics for Nervous System Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Italy Digital Therapeutics for Nervous System Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Russia Digital Therapeutics for Nervous System Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Nordic Countries Digital Therapeutics for Nervous System Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Digital Therapeutics for Nervous System Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Asia-Pacific Digital Therapeutics for Nervous System Diseases Market Share by Region (2020-2031)
 Figure 34. China Digital Therapeutics for Nervous System Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Japan Digital Therapeutics for Nervous System Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. South Korea Digital Therapeutics for Nervous System Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Southeast Asia Digital Therapeutics for Nervous System Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. India Digital Therapeutics for Nervous System Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Australia Digital Therapeutics for Nervous System Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Digital Therapeutics for Nervous System Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Latin America Digital Therapeutics for Nervous System Diseases Market Share by Country (2020-2031)
 Figure 42. Mexico Digital Therapeutics for Nervous System Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Brazil Digital Therapeutics for Nervous System Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Digital Therapeutics for Nervous System Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East & Africa Digital Therapeutics for Nervous System Diseases Market Share by Country (2020-2031)
 Figure 46. Turkey Digital Therapeutics for Nervous System Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Saudi Arabia Digital Therapeutics for Nervous System Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. UAE Digital Therapeutics for Nervous System Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. Zoecare Revenue Growth Rate in Digital Therapeutics for Nervous System Diseases Business (2020-2025)
 Figure 50. 66nao Revenue Growth Rate in Digital Therapeutics for Nervous System Diseases Business (2020-2025)
 Figure 51. MedRhythms Revenue Growth Rate in Digital Therapeutics for Nervous System Diseases Business (2020-2025)
 Figure 52. Curelator Revenue Growth Rate in Digital Therapeutics for Nervous System Diseases Business (2020-2025)
 Figure 53. Sanofi Revenue Growth Rate in Digital Therapeutics for Nervous System Diseases Business (2020-2025)
 Figure 54. GYENNO SCIENCE Revenue Growth Rate in Digital Therapeutics for Nervous System Diseases Business (2020-2025)
 Figure 55. Cognito Therapeutics Revenue Growth Rate in Digital Therapeutics for Nervous System Diseases Business (2020-2025)
 Figure 56. Nanjing Vishee Medical Technology Co.,Ltd. Revenue Growth Rate in Digital Therapeutics for Nervous System Diseases Business (2020-2025)
 Figure 57. Glecan Revenue Growth Rate in Digital Therapeutics for Nervous System Diseases Business (2020-2025)
 Figure 58. Xinkangyx Revenue Growth Rate in Digital Therapeutics for Nervous System Diseases Business (2020-2025)
 Figure 59. WonderLab Revenue Growth Rate in Digital Therapeutics for Nervous System Diseases Business (2020-2025)
 Figure 60. BestCovered, Ltd. Revenue Growth Rate in Digital Therapeutics for Nervous System Diseases Business (2020-2025)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS

Global Digital Therapeutics for Psychiatric Illnesses Market Research Report 2024
Global Digital Therapeutics for Endocrine System Diseases Market Research Report 2024
Global Digital Nervous System Market Research Report 2024
Global Digital Therapeutics Platforms for Mental Health Market Research Report 2024
Global Digital Therapeutics Platforms Market Research Report 2024
Global Drugs for Central Nervous System Diseases Market Insights Forecast to 2030
Global Digital Therapy for Mental Disorders Market Research Report 2025
Neurology Digital Therapeutics Market
Global Dementia Digital Therapeutics Market Research Report 2024
Digital Psychotherapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Nervous System Chemicals Market Research Report 2024
Global Neurodegenerative Disorder Therapeutics Market Research Report 2024
Global Neurodegenerative Disease Treatment Market Research Report 2024
Global Clinical Trial Digitalization Market Research Report 2025
Global Neurodegenerative Disease Market Insights Forecast to 2030
Global Prescription Digital Therapeutics PDT Market Research Report 2024
Global Neurologic Disorders Therapeutics Market Insights Forecast to 2030
Digital Healthcare Software Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Digital Therapeutics and Wellness Market Insights Forecast to 2030
Central Nervous System Disorders Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions